Therapeutic Asset Ratings
12,938 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Rly-5836
Hormone Receptor Positive Tumor
Relay Therapeutics, Inc.
P1
CC
(46)
Rly-5836
PIK3CA Mutation
Relay Therapeutics, Inc.
P1
CC
(46)
Rly-5836
Unresectable Solid Tumor
Relay Therapeutics, Inc.
P1
CC
(46)
Romidepsin
Enteropathy-Associated T-Cell Lymphoma
National Cancer Institute (NCI)
P1
CC
(46)
Rosuvastatin
Cancer
PMV Pharmaceuticals, Inc
P1
CC
(46)
Rosuvastatin
HER2 Mutation
Bayer
P1
CC
(46)
Rosuvastatin
Tuberous Sclerosis Complex (TSC)
GRIN Therapeutics, Inc.
P1
CC
(46)
rp12146
Breast Cancer
Rhizen Pharmaceuticals SA
P1
CC
(46)
sim1910-09
Brain Edema
Jiangsu Simcere Pharmaceutical Co., Ltd.
P1
CC
(46)
sl-172154
Fallopian Tube Carcinoma
Shattuck Labs, Inc.
P1
CC
(46)
Stiripentol
Dravet Syndrome
Biocodex
P1
CC
(46)
stp705
Abdominal Obesity
Sirnaomics
P1
CC
(46)
Suplexa
Neoplasm
Alloplex Biotherapeutics Inc
P1
CC
(46)
Survodutide
Liver Disorder
Boehringer Ingelheim
P1
CC
(46)
t2026
Type 2 Diabetes Mellitus
Sciwind Biosciences APAC CO Pty. Ltd.
P1
CC
(46)
Talzenna
Advanced or Recurrent Solid Tumors
Center Trials & Treatment
P1
CC
(46)
Tbio-4101
Ocular Melanoma
H. Lee Moffitt Cancer Center and Research Institute
P1
CC
(46)
Tbio-4101
Melanoma
H. Lee Moffitt Cancer Center and Research Institute
P1
CC
(46)
TCR .ALPHA..BETA. (RECEPTOR), ANTI-(HUMAN P53 (PROTEIN)) (SYNTHETIC HUMAN SINGLE-CHAIN PRECURSOR) FUSION PROTEIN WITH INTERLEUKIN 2 (HUMAN)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Altimmune, Inc.
P1
CC
(46)
TEMUTERKIB
Non-Small Cell Lung Carcinoma
The Netherlands Cancer Institute
P1
CC
(46)
TEONANACATL
Hematopoietic And Lymphoid Cell Neoplasm
Emory University
P1
CC
(46)
Thiscart19A
B-Cell Acute Lymphoblastic Leukemia
Zhejiang University
P1
CC
(46)
Tisotumab Vedotin
Cancer
Zai Lab (Shanghai) Co., Ltd.
P1
CC
(46)
TRASTUZUMAB
Metastatic Carcinoma In The Bone
City of Hope Medical Center
P1
CC
(46)
Trastuzumab Deruxtecan
Refractory Malignant Neoplasm
M.D. Anderson Cancer Center
P1
CC
(46)
Showing 751 to 775 of 12,938 assets
Previous
Page 31 of 518
Next
